ERK2-ZEB1-miR-101-1 axis contributes to epithelial-mesenchymal transition and cell migration in cancer

Cancer Lett. 2017 Apr 10:391:59-73. doi: 10.1016/j.canlet.2017.01.016. Epub 2017 Jan 18.

Abstract

Regulation of metastasis continues to remain enigmatic despite our improved understanding of cancer. Identification of microRNAs associated with metastasis in the recent past has provided a new hope. Here, we show how microRNA-101 (miR-101) regulates two independent processes of cellular metastasis by targeting pro-metastatic upstream regulatory transcription factors, ZEB1 and ZEB2, and downstream effector-actin modulators, RHOA and RAC1, providing a single target for therapeutic intervention. Further, we depict how down-regulation of miR-101 by extracellular signal-regulated kinase-2 (ERK2) is vital for MAP kinase pathway induced cellular migration and mesenchymal transition. Importantly, EKR2 induced expression of ZEB1 seems essential for down-regulation of miR-101-1 and induction of EMT. Given the role of EMT in metastasis, we also observe a significant correlation between miR-101 expression and lymph node metastasis; and identify the ERK2-ZEB1-miR-101-1 pathway active in breast cancer tissues, with an apparent clinicopathological implication.

Keywords: Breast cancer; Cytoskeleton; EMT-TFs; Epidermal growth factor (EGF); miR-101; microRNA.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Cell Line, Tumor
  • Cell Movement
  • Epithelial-Mesenchymal Transition
  • Humans
  • MicroRNAs / metabolism*
  • Mitogen-Activated Protein Kinase 1 / metabolism*
  • Transfection

Substances

  • MicroRNAs
  • Mitogen-Activated Protein Kinase 1